ANGLE plc

ANGLE plc

ANGLE plc

Overview
Date Founded

2003

Headquarters

The Surrey Research Park,10 Nugent Road,Guildford, Surrey GU2 7AF

Type of Company

Public

Employees (Worldwide)

51 - 100

Industries

Management Consulting
IT Consulting & Services
Medical Support Services
Wholesale: Medical Supplies & Pharmaceuticals
Hospitals & Patient Services
Holding Companies
Commercial Scientific Research
Advertising & Marketing

Company Description

ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.

Contact Data
Trying to get in touch with decision makers at ANGLE plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer, Secretary & Executive Director

Chief Scientific Officer

Vice President, Chief Executive Officer Angle BioSciences, Inc

Head of Clinical Laboratories

Associate Commercial Director

Director-Manufacturing & Regulatory Affairs

Director-Business Development

Vice President-NA

Board of Directors

Former Chief Executive Officer at Comino Group Plc

Founder at ANGLE plc

Chief Executive Officer & Director at Novigenix SA

Paths to ANGLE plc
Potential Connections via
Relationship Science
You
ANGLE plc
Owners & Shareholders
Details Hidden

KW Investment Management focuses on protecting the long-term value of their clients’ wealth. The firm manages growth whilst carefully protecting against risk.

Recent Transactions
Details Hidden

ANGLE plc purchases Axela, Inc. /Certain Assets from Axela, Inc.

Details Hidden

SVF Holdco (UK) Ltd. purchases Geomerics Ltd. from ANGLE plc

Details Hidden

ANGLE plc issued GBP Ordinary Shares

Transaction Advisors
Broker

Advised onANGLE plc issued GBP Ordinary Shares

Auditor

Advised onANGLE plc issued GBP Ordinary Shares

Broker

Advised onANGLE plc issued GBP Ordinary Shares

Key Stats and Financials As of 2019
Market Capitalization
$260M
Total Enterprise Value
$109M
Earnings Per Share
$-0.07
EBITDAMargin
-1,174.87%
Enterprise Value / Sales
98.01x
TEVNet Income
-9.11x
Debt TEV
0.02x
Three Year Compounded Annual Growth Rate Of Revenue
34.15%
Revenue
$1.11M
Net Profit
$-11.9M
EBITDA
$-13M
Total Debt
$1.98M
Total Equity
$38.6M
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ANGLE plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ANGLE plc's profile does not indicate a business or promotional relationship of any kind between RelSci and ANGLE plc.